Skip to content

Nuvation Bio NUVB Interest coverage

Interest coverage at other companies

Arcus Biosciences logo
Arcus BiosciencesRCUS
-39.8×-15.5×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-55,882.3×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-5×-1.1×
Summit Therapeutics logo
Summit TherapeuticsSMMT
-26×
Roivant Sciences logo
Roivant SciencesROIV
122.5×+104×
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
582×

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

Based on trailing twelve months.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's interest coverage?
Nuvation Bio (NUVB) reported interest coverage of -7.4× in Q1 2026.
How has Nuvation Bio's interest coverage changed year-over-year?
Nuvation Bio's interest coverage increased by 99.5% year-over-year, from -1,598.6× to -7.4×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.